Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
about
The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.Enzyme-Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review.Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications.Vascular complications in diabetes: old messages, new thoughts.Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy.Avocado oil induces long-term alleviation of oxidative damage in kidney mitochondria from type 2 diabetic rats by improving glutathione status.Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.[Skeletal muscle aging and mitochondrial dysfunction: an update].Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice.The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.Glomerular Endothelial Cells Stress and Cross-Talk With Podocytes in the Development of Diabetic Kidney Disease.Acute Kidney Injury and Progression of Diabetic Kidney Disease.Preventing the Progression of AKI to CKD: The Role of Mitochondria.The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
P2860
Q37541642-3C3AA2F0-F2A8-4682-AAD1-76C9FADD02BBQ37678309-C684BCD0-36EE-4D4E-86AD-2643841556F0Q38678059-3EA86849-E334-4D35-84A8-24961F25BFA8Q39107426-C73EDC45-895F-467F-AD18-ECB34BE65CB9Q39446720-BA295FDF-5560-4A25-AD98-FF78BC9BDB8BQ41548664-A97D6DA1-D91F-493B-9714-9C3FBA332BC4Q46325575-A444ADAC-F831-498E-8E16-9CD43EDE14FAQ46329158-879E7FEC-7605-4B13-972F-A4913C44E4C9Q46415696-D3D7C608-70C4-41A5-A5DC-0DFAB3A356C9Q46455327-75E16AEF-3DF5-41AF-9070-B75C20BBCA57Q47103818-CA57DC35-EF30-4BCE-B1D8-2E6B98580B96Q50098090-E48370C1-1CFC-4193-8771-6DAB94D47797Q50189074-FF543782-2465-40BD-829E-28FEC27676DDQ51210259-91F589C8-9146-423A-9C23-C70999C59B21Q52599406-4D9F0094-D283-44BC-9BC7-F33CDB7237DEQ52724019-EA22BD76-9353-4D4A-9E1A-860C796963C2Q54287609-F9A41641-41F0-41FA-ADC1-2192C87A00C8Q58116200-C088FDBD-03AC-48D2-8550-CCC55D658A97
P2860
Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@en
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@nl
type
label
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@en
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@nl
prefLabel
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@en
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@nl
P2093
P2860
P1476
Mitochondria-targeted peptide ...... ffect in diabetic nephropathy.
@en
P2093
Chunyang Du
Haijiang Wu
Huijun Duan
Jinying Wei
Shuangcheng Li
Yanjuan Hou
Yonghong Shi
Yunzhuo Ren
P2860
P304
P356
10.1152/AJPRENAL.00574.2014
P577
2015-12-30T00:00:00Z